Olampus Pharmaceuticals Private Limited
About Olampus Pharmaceuticals Private Limited
Data last updated:
Olampus Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 10 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51397BR2010PTC015303. Its GSTIN is 10AABCO2490E1Z0 (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Nitesh Mishra and Rajeev Ranjan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mig – 76 Lohia Nagar Kankarbag, Patna, Bihar, India – 800020.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.41 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹71,901 (net margin 1.5%) and EBITDA of ₹1.03 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Olampus Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMig – 76 Lohia Nagar Kankarbag, Patna, Bihar, India – 800020
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Olampus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Olampus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Olampus Pharmaceuticals Private Limited, buy the company report.
Financials of Olampus Pharmaceuticals Private Limited
FY 2024 filings availableOlampus Pharmaceuticals Private Limited reported revenue of ₹49.41 Lakh (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 9% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹71,901 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Olampus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Olampus Pharmaceuticals Private Limited
Olampus Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitesh Mishra | Director | 10 Feb 2010 | 16 Years 9 Months | Current |
| Rajeev Ranjan | Director | 10 Feb 2010 | 16 Years 9 Months | Current |
| Amrita Mishra | Director | 14 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Olampus Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xenomics Pharmaceuticals Private Limited | ₹49.71 Lakh (FY 2024) | 53.0% | Hyderabad, Telangana, India | |||
| Vancorp Pharmaceuticals Private Limited | ₹49.64 Lakh (FY 2025) | 3.0% | Gautam Budh Nagar, Uttar Pradesh, India | |||
| Reinheit Pharmaceuticals Private Limited | ₹49.48 Lakh (FY 2024) | 132.0% | Kolkata, West Bengal, India | |||
| Olampus Pharmaceuticals Private Limitedthis company | ₹49.41 Lakh (FY 2024) | ₹71,901 | 1.5% | 9.0% | Patna, Bihar, India |
To see the full peer comparison of Olampus Pharmaceuticals Private Limited, buy the company report.
Auditor
Olampus Pharmaceuticals Private Limited is audited by SANJAY KUMAR JHA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY KUMAR JHA & ASSOCIATES | FY 2017 | 006329C |
Shareholding
The shareholding of Olampus Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Olampus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Olampus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Olampus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Olampus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCO2490E1Z0 | Bihar | Active | 26 Jul 2017 |
To see the full GST registrations and return filing status of Olampus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Olampus Pharmaceuticals Private Limited has 6 board changes on record since 2010: 3 appointments and 3 cessations. The latest: Amrita Mishra ceased to be Additional Director on 30 Oct 2020.
Frequently asked questions
Olampus Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 10 February 2010 (16+ years old) and is registered under CIN U51397BR2010PTC015303.
Olampus Pharmaceuticals has 3 current directors:
- Nitesh Mishra - Director
- Rajeev Ranjan - Director
- Amrita Mishra - Director
The latest financial statements of Olampus Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Olampus Pharmaceuticals is 10AABCO2490E1Z0, registered in Bihar.
The CIN (Corporate Identification Number) of Olampus Pharmaceuticals is U51397BR2010PTC015303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olampus Pharmaceuticals was incorporated on 10 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Olampus Pharmaceuticals by revenue are Xenomics Pharmaceuticals Private Limited, Vancorp Pharmaceuticals Private Limited, Reinheit Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amrita Mishra ceased to be Additional Director on 30 Oct 2020. Amrita Mishra was appointed as Director on 14 Oct 2020. Anish Narayan ceased to be Director on 12 Oct 2020. Olampus Pharmaceuticals has 6 board changes on record in total.
The registered office of Olampus Pharmaceuticals is at Mig – 76 Lohia Nagar Kankarbag, Patna, Bihar, India – 800020.
Olampus Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Olampus Pharmaceuticals is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
